Table 2. Linear correlation analyze among prostaglandin E2 metabolite concentration and clinical parameters.
Plasma-PGEM (pg/ml) | Urine-PGEM (ng/ml) | |||
---|---|---|---|---|
r | P | r | P | |
Age (years) | -0.200 | 0.263 | 0.009 | 0.961 |
Onset age (years) | -0.290 | 0.101 | -0.075 | 0.678 |
BMI(kg/m2) | 0.143 | 0.505 | 0.093 | 0.657 |
SBP(mmHg) | 0.164 | 0.396 | 0.138 | 0.476 |
eGFR | 0.068 | 0.715 | -0.019 | 0.918 |
QTc(sec) | -0.048 | 0.826 | -0.116 | 0.580 |
Serum K+(mmol/L) | -0.146 | 0.418 | -0.200 | 0.266 |
Serum Na+(mmol/L) | 0.091 | 0.615 | 0.269 | 0.130 |
Serum Cl-(mmol/L) | -0.286 | 0.107 | -0.409 | 0.018 |
Serum Mg2+(mmol/L) | 0.032 | 0.860 | -0.374 | 0.032 |
Serum Ca2+(mmol/L) | 0.553 | 0.001 | -0.059 | 0.746 |
Serum P(mmol/L) | 0.086 | 0.632 | -0.084 | 0.640 |
24h Urinary K+(mmol/d) | 0.117 | 0.518 | 0.014 | 0.938 |
24h Urinary Na+(mmol/d) | 0.061 | 0.735 | 0.349 | 0.050 |
24h Urinary Cl-(mmol/d) | 0.006 | 0.972 | 0.300 | 0.102 |
24h Urinary Mg2+(mmol/d) | 0.219 | 0.238 | 0.094 | 0.615 |
24h Urinary Ca2+(mmol/d) | -0.091 | 0.621 | -0.443 | 0.013 |
24h Urinary P(mmol/d) | 0.097 | 0.605 | -0.035 | 0.853 |
Urinary Ca2+/Cr ratio | -0.369 | 0.045 | -0.108 | 0.585 |
Blood gas cHCO3-(mmol/L) | 0.098 | 0.589 | 0.428 | 0.013 |
Blood gas ABE(mmol/L) | 0.119 | 0.508 | 0.544 | 0.001 |
Upright Renin(ng/ml/h) | -0.040 | 0.838 | 0.171 | 0.376 |
Upright Angiotensin II(pg/ml) | 0.325 | 0.085 | 0.073 | 0.707 |
Upright Aldosterone(ng/dl) | -0.138 | 0.482 | 0.004 | 0.982 |
ΔClearance Cl in HCT test(ml/min) | 0.130 | 0.619 | -0.321 | 0.226 |
Abbreviations: ABE, actual base excess; eGFR, estimated glomerular filtration rate, ml/min/1.73m2; GS, Gitelman syndrome; SBP, systolic blood pressure; PGEM, prostaglandin E2 metabolite; ΔClearance Cl, the absolute increases in the chloride learance rate; HCT, hydrochlorothiazide